agilon health inc.
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$1.90B
Cash Runway
30.1 mo
Lead Asset
—
Next Catalyst
—
Go deeper on agilon health inc. with Spotter
Ask follow-up questions and run a full multi-agent deep dive on AGL — live, with citations.
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
30.1 months
OCF $24M · Net income $49M
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
4 buys · 0 sells (180d)
Key Financialsas of March 31, 2026
Cash
$211.6M
Quarterly Burn
$54.2M
Revenue
$1.42B
Free Cash Flow
$20.6M
Total Liabilities
$1.32B
Current Ratio
1.04
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Commercialization & Governance
Commercialization
- Partnerships
- Anchor physician groups (community-based PCPs), health plan payors (large national health plans and smaller local/regional insurers), CMS through participation in ACO REACH Model and MSSP (nine approved ACOs), hospitals, specialists and ancillary providers, and national payors with multi-geography contracts.
- Launch Markets
- ConnecticutGeorgiaIllinoisKentuckyMichiganMinnesotaNew YorkNorth CarolinaOhioPennsylvaniaTennesseeTexas
- Commercial Strategy
- Grow by partnering with leading community-based physician groups via long-term (typically 20-year) partnerships deployed through a purpose-built platform. Form local risk-bearing entities (RBEs) that enter into subscription-like per-member-per-month (PMPM) global capitation agreements with payors, share savings with anchor physician groups, and support physician adoption through technology, people, process, capital and a dedicated business development team. Establish local branding (typically anchor partner's name plus 'Senior Health Connect') and develop educational communications to support Medicare-eligible patients. Marketing to consumers is performed by health plans/payors per CMS guidelines; company focuses on outreach to physician groups and local branding/support.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
96
Total value held
$92.7M
| Holder | Shares | Value |
|---|---|---|
| morgan stanley | 2,099,451 | $16.6M |
| north peak capital management, llc | 1,545,537 | $12.2M |
| vanguard capital management llc | 1,077,072 | $8.5M |
| goldman sachs group inc | 1,062,236 | $8.4M |
| aqr capital management llc | 974,897 | $7.7M |
| blackrock, inc. | 873,164 | $6.9M |
| d. e. shaw & co., inc. | 742,218 | $5.9M |
| charles schwab investment management inc | 364,499 | $2.9M |
| jacobs levy equity management, inc | 296,552 | $2.3M |
| geode capital management, llc | 266,112 | $2.1M |
Showing top 10 of 96 institutional holders of agilon health inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
Who is the CEO of agilon health inc.?
Mr. Timothy Patrick O'Rourke is the chief executive officer of agilon health inc. (AGL).
Where is agilon health inc. headquartered?
agilon health inc. (AGL) is headquartered in Westerville, OH, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on agilon health inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.